Martin C. Maxwell Sells 8,720 Shares of Integer Holdings Co. (NYSE:ITGR) Stock

Integer Holdings Co. (NYSE:ITGR - Get Free Report) Director Martin C. Maxwell sold 8,720 shares of the company's stock in a transaction dated Thursday, June 5th. The stock was sold at an average price of $120.56, for a total transaction of $1,051,283.20. Following the completion of the transaction, the director now owns 22,170 shares of the company's stock, valued at approximately $2,672,815.20. This trade represents a 28.23% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink.

Integer Price Performance

Shares of NYSE:ITGR traded up $0.35 during trading on Friday, reaching $121.25. The stock had a trading volume of 234,023 shares, compared to its average volume of 374,978. The company has a debt-to-equity ratio of 0.62, a quick ratio of 2.09 and a current ratio of 2.95. Integer Holdings Co. has a 1-year low of $104.93 and a 1-year high of $146.36. The stock has a market cap of $4.23 billion, a PE ratio of 36.09, a PEG ratio of 1.72 and a beta of 1.03. The business has a fifty day moving average price of $118.75 and a 200-day moving average price of $128.20.

Integer (NYSE:ITGR - Get Free Report) last released its earnings results on Thursday, April 24th. The medical equipment provider reported $1.31 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.27 by $0.04. The business had revenue of $437.39 million during the quarter, compared to analyst estimates of $428.51 million. Integer had a net margin of 6.92% and a return on equity of 11.65%. The company's revenue for the quarter was up 7.3% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.14 earnings per share. On average, equities analysts forecast that Integer Holdings Co. will post 6.01 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research firms have recently commented on ITGR. Wall Street Zen upgraded Integer from a "sell" rating to a "hold" rating in a research report on Monday, May 19th. KeyCorp dropped their price objective on Integer from $154.00 to $145.00 and set an "overweight" rating on the stock in a report on Monday, April 21st. Truist Financial set a $150.00 target price on Integer and gave the stock a "buy" rating in a research note on Friday, April 25th. Raymond James increased their target price on Integer from $145.00 to $150.00 and gave the company an "outperform" rating in a research report on Friday, April 25th. Finally, Benchmark cut their price target on shares of Integer from $150.00 to $140.00 and set a "buy" rating for the company in a report on Friday, April 25th. Two research analysts have rated the stock with a hold rating, seven have issued a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of $145.00.

Institutional Trading of Integer

Several large investors have recently bought and sold shares of the business. Strs Ohio purchased a new position in Integer in the 1st quarter worth approximately $283,000. Intech Investment Management LLC increased its holdings in shares of Integer by 92.8% in the first quarter. Intech Investment Management LLC now owns 22,682 shares of the medical equipment provider's stock valued at $2,677,000 after purchasing an additional 10,915 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its holdings in shares of Integer by 4.7% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 109,316 shares of the medical equipment provider's stock valued at $12,900,000 after purchasing an additional 4,873 shares during the last quarter. Axiom Investors LLC DE purchased a new position in Integer during the first quarter worth approximately $4,457,000. Finally, United Services Automobile Association acquired a new position in Integer during the first quarter worth $258,000. Hedge funds and other institutional investors own 99.29% of the company's stock.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.